Navigation Links
Pipeline for New Obesity Therapies is Focus of New Report
Date:1/7/2008

tta (exenatide; Amylin/Lilly), exenatide LAR (Lilly/Amylin/Alkermes), exenatide + recombinant leptin (r-metHuLeptin; Amylin/Amgen), Symlin (pramlintide; Amylin), pramlintide + AC162352 (PYY 3-36; Amylin), liraglutide (NN2211; Novo Nordisk), albiglutide (GSK / Human Genome Science), PC-DAC:Exendin-4 (ConjuChem), Boc5 (SH-7871; UC Riverside / Chinese Academy of Science); Substituted quinoxalines (Novo Nordisk/ Pfizer), PYY 3-36 (Nastech), CYT009-GhrQb (Cytos), Xenical / alli (orlistat; Roche / GSK), cetilistat (Alizyme/ Takeda), SGLT inhibitors.

This report can be purchased by contacting MedPredict.

About MedPredict

MedPredict (http://www.medpredict.com) maintains a proprietary database of over 1,000 global physician thought leaders, including 40+ specialties in 30+ therapeutic categories. Based on primary interviews with these thought leaders, MedPredict publishes periodic reports in each category to keep clients up-to-date on emerging trends and competitive activity. The reports include thought leader reactions to recent publications and medical conferences, as well as clinical, regulatory and marketing activity.


'/>"/>
SOURCE MedPredict
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
2. Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
3. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
4. S*BIO Expands Pipeline With the Development of a Unique Flt3 -CDK Inhibitor as a Targeted Therapy for Acute Leukemias
5. China Holdings, Inc. Announces Its 3rd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 150 MW in Biomass Energy Pipeline
6. Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.s Drug Pipeline
7. Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Councils Ninth Annual MASS Opportunities Investment Conference
8. China Holdings, Inc. Announces 2nd Biomass Renewable Energy Project (Power Capacity: 50 MW); Total Potential: 100 MW in Biomass Energy Pipeline
9. Clinical studies in the pipeline: the therapies of tomorrow in trials today
10. Isis Adds New Drug to Its Development Pipeline: ISIS 388626 Targeting SGLT2 for the Treatment of Type 2 Diabetes
11. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR-NCI-EORTC International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/2/2015)... April 02, 2015 “ SmartenFit ” was ... takes a look at the latest and coolest ... Troohey, the host of AppWatch and technology expert, conducted the ... for people looking for a sustainable healthy lifestyle. , Health ... SmartenFit is a new application that covers health from a ...
(Date:4/2/2015)... April 02, 2015 As spring weather ... gets its start! Runners have been putting in the ... start racing. Zensah®, a premium compression apparel brand, is ... the athletes are benefiting from compression in ... a Miami-based company, committed to using the best fabrics ...
(Date:4/2/2015)... April 02, 2015 Memphis, TN: MedixSafe Vanguard ... safes, cabinets, and lockers to meet security demands ... facility down to an ambulance service keeping limited narcotics ... 2 provides triple security-plus technology® with a wireless connection ... to monitor narcotics access 24/7. , MedixSafe Vanguard 2 ...
(Date:4/2/2015)... New York Dynamic Neuromuscular Rehabilitation & Physical ... New York City, a groundbreaking, conservative method of treatment ... other types of neurological diseases that damage the ability ... is considered a cerebrovascular accident (CVA) that causes an ... in damage to the nerve cells. Damage to the ...
(Date:4/1/2015)... In April, the Science Museum of Virginia will ... by illuminating Richmond’s historic train station with blue lights. ... of businesses, schools and organizations who will ‘go blue’ ... up the night sky – and the future of ... the 8th annual awareness campaign spearheaded by Autism Speaks, ...
Breaking Medicine News(10 mins):Health News:An Application for Long Term Sustainable Lifestyle Change Was Featured on NewsWatch Television 2Health News:Zensah® Partners With Austin Track Club 2Health News:Zensah® Partners With Austin Track Club 3Health News:MedixSafe Introduces New High Tech Narcotics Security Solution - Vanguard 2 2Health News:Virtual Environment Treatment Available for the First Time in NYC for Patients with Stroke 2
... ,In the 30 years since the first reported cases ... have made extraordinary advances in understanding, treating and preventing ... the National Institute of Allergy and Infectious Diseases (NIAID), ... build on those successes to control and, ultimately, end ...
... New England Journal of Medicine , physicians and ... successful treatment of three young children who were suffering ... with enterohemorrhagic Escherichia coli (EHEC). The infections ... the current wave of infections that have already claimed ...
... a world-leading publisher of scientific, technical and medical information ... of a new journal, International Journal of Paleopathology ... quarterly, the first issue of the journal is now ... copies of the first issue will be available at ...
... Researchers at Children,s Hospital Boston and Google.org have found web-based ... early detection and monitoring of outbreaks of dengue, an emerging ... search data allows the capture of disease-related queries in near ... more than 100 countries affected by dengue respond more quickly ...
... , MONDAY, May 30 (HealthDay News) -- Although stress ... person,s risk for developing the disease in the first place, ... than 100,000 nurses each, ranging in age from 24 to ... Those examined were asked about their levels of stress both ...
... ST. PAUL, Minn. Contrary to earlier reports, a new ... person,s risk of developing multiple sclerosis (MS). The research is ... Neurology , the medical journal of the American Academy of ... have been shown to increase the risk of MS episodes, ...
Cached Medicine News:Health News:Antibodies successful in the treatment of the hemolytic-uremic syndrome from EHEC 2Health News:Elsevier launches new journal: International Journal of Paleopathology 2Health News:Searching the web for dengue 2
(Date:4/1/2015)... , April 1, 2015 International Isotopes Inc. ... fiscal year ended December 31, 2014.  The Company reports ... net loss, and positive cash flow for the year ... revenue in 2014 was approximately $7.5 million compared to ... of approximately 10%.  With the exception of the radiological ...
(Date:4/1/2015)... , April 1, 2015 ... ), a clinical-stage pharmaceutical company focused on the development ... patient has been enrolled in its Glucose Clamp Study. ... Texas Health Science Center at San Antonio ... under the supervision of Professor Ralph DeFronzo . ...
(Date:4/1/2015)... , April 1, 2015  Egalet Corporation ... specialty pharmaceutical company focused on developing, manufacturing and ... of an offering of $60.0 million aggregate principal ... (the "notes") in a private placement to qualified ... Securities Act of 1933, as amended (the "Act"). ...
Breaking Medicine Technology:International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7
... NEW YORK, Sept. 13, 2011 IMMUNE ... based Therapeutics for the treatment of inflammatory diseases and ... M.D., Ph.D., to the position of Chief Medical Officer.  ... pivotal  role in the development of Bertilimumab, IMMUNE,s phase ...
... DIEGO, Sept. 13, 2011 Sequenom, Inc. (NASDAQ: ... solutions, today announced the Company,s participation at the UBS Global ... in New York City September 19-21, 2011. ... Development, will present on Monday, September 19, 2011 beginning at ...
Cached Medicine Technology:IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer 2IMMUNE Pharmaceuticals Announces Alan G. Harris MD, PhD, FRCP as Chief Medical Officer 3Sequenom Announces Participation at UBS Global Life Sciences Conference 2
... cool and your patient warm, with ... cooling system.,Designed around the Coanda Effect, ... localized air flow around your torso's ... during the heat and stress induced ...
... System is designed to provide excellent capture ... carotid stenting interventions. The ACCUNET is a ... utilizes rapid exchange technology so that the ... catheter manipulations. It is available in both ...
... The Precision PCx point of ... a whole-blood, patient-side testing system for ... use, the system provides fast, accurate ... hospital and laboratory information systems enables ...
Representing the next step in the evolution of point-of-care testing, the i-STAT 1 Analyzer uses one platform to perform glucose strip testing along with all i-STAT test cartridges....
Medicine Products: